Faeth Therapeutics, Inc. (FTH)
Market Closed
1 Sep, 20:00
NASDAQ (CM) NASDAQ (CM) Primary $
34. 51
+1.74
+5.3097%
After Hours
$
+2.49 +7.2153% 37. 00
844.77M Market Cap
- P/E Ratio
- Div Yield
276,713 Volume
- Eps
$ 32.77
Previous Close 
Want to track FTH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Faeth Therapeutics, Inc. (FTH) Statistics
Valuation metrics
Market Cap 844.77M
Enterprise value 846.04M
Trailing P/E (ttm) -0.24
Forward P/E -
PEG ratio 0
Price/Sales (ttm) -179.83
Price/Book (mrq) 1.1
Enterprise Value/Revenue -174.41
Enterprise Value/EBITDA -4.33
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 274.4K
Average volume (90 days) 189.44K
Price summary
52-Week low 7.45
52-Week high 37.9
Beta -
50-Day moving average 29.35
200-Day moving average 25.28
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:20
Last split Date 17 Jun 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 40.31%
Operating margin 40.99%
Operational effectiveness
Return on assets -1.03%
Return on equity -1.93%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -0.86
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -34.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 33.04
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 19.69%
Book value per share (mrq) 30.65
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
